Mar 6, 2019

FDA approves fast-acting antidepressant nasal spray, esketamine

Photo: David Cheskin - PA Images/Getty Images

The Food and Drug Administration (FDA) approved a fast-acting nasal treatment for depression Tuesday to be marketed under the name Spravato, intended to help adults who live with severe depression that have not responded to other treatments.

Why it matters: Nearly 16 million American adults are currently diagnosed with depression, of which as many as 5 million fail to respond to existing treatments, reports the Washington Post. The new drug, developed by Janssen Pharmaceuticals Inc., an arm of Johnson & Johnson, comes in the form of a nasal spray called esketamine and can be effective within hours, rather than the weeks or months typical of other antidepressants, such as Prozac.

Details: The FDA approval requires that doses be given in certified settings such as a doctor's office or clinic, and that patients be monitored for at least 2 hours in case of side effects, such as disassociation. In addition, the packaging for the new treatment will contain a so-called "black box" warning label — the most serious category — indicating potential sedation, problems with attention, judgment and thinking, as well as abuse and suicidal thoughts.

But, but, but: The drug, which contains an active form of ketamine, has antidepressant properties that are not entirely understood, particularly when it comes to its long-term effects, Jeffrey Lieberman, a Columbia University psychiatrist told the Post.

The bottom line: Esketamine represents the first depression drug in years to be approved that works via a completely different mechanism in the brain, as compared to the previous generation of medications. For many with treatment-resistant depression, the new drug offers newfound hope of relief.

Go deeper

Coronavirus updates: World case count tops 600,000

Data: The Center for Systems Science and Engineering at Johns Hopkins, the CDC, and China's Health Ministry. Note: China numbers are for the mainland only and U.S. numbers include repatriated citizens and confirmed plus presumptive cases from the CDC

Japanese Prime Minister Shinzo Abe warned that the novel coronavirus pandemic could worsen if people fail to take the appropriate containment measures, at a Saturday news conference in Tokyo.

The big picture: The U.S. leads the world in confirmed coronavirus cases, as the number of global cases nears 620,000. Governments around the world are trying to curb the medical and financial fallout of COVID-19, as infections surge across Europe and the U.S.

Go deeperArrowUpdated 9 mins ago - Health

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 11 a.m. ET: 618,043 — Total deaths: 28,823 — Total recoveries: 135,736.
  2. U.S.: Leads the world in cases. Total confirmed cases as of 11 a.m. ET: 104,865 — Total deaths: 1,709 — Total recoveries: 894.
  3. Federal government latest: President Trump signed the $2 trillion coronavirus stimulus bill to provide businesses and U.S. workers economic relief.
  4. State updates: A group of Midwestern swing voters that supported President Trump's handling of the coronavirus less than two weeks ago is balking at his call for the U.S. to be "opened up" by Easter. Alaska is latest state to issue stay-at-home order — New York is trying to nearly triple its hospital capacity in less than a month.
  5. World updates: Italy reported 969 coronavirus deaths on Friday, the country's deadliest day. In Spain, over 1,300 people were confirmed dead between Thursday to Saturday.
  6. Business latest: President Trump authorized the use of the Defense Production Act to direct General Motors to build ventilators for those affected by COVID-19. White House trade adviser Peter Navarro has been appointed to enforce the act.
  7. What should I do? Answers about the virus from Axios expertsWhat to know about social distancing.
  8. Other resources: CDC on how to avoid the virus, what to do if you get it.

Subscribe to Mike Allen's Axios AM to follow our coronavirus coverage each morning from your inbox.

The one-minute coronavirus story

Illustration: Sarah Grillo/Axios

News about the coronavirus is so big and coming so fast that it's hard to remember what happened just last week, let alone last month.

Here's the quickest possible review of the story so far — how it happened and how the U.S. lost control.

Go deeperArrow3 hours ago - Health